Casinos.com Announces Results From Tribal Gaming Community Impact Voting
Voted entirely by locals, the results recognize standout casino venues across four U.S. states and three Canadian provinces where tribal and First Nations gaming venues have a heavy presence. Locals were asked to vote for the casino in their area that has had the most significant community impact, whether that be through funding and donations or excellent entertainment services.
Voting Recognizes Seven Standout Casinos for Cultural Impact
The public voting campaign was conducted as part of Casinos.com's Tribal Casinos Month initiative, dedicated to honoring the achievements, cultural contributions, and economic impact of Indigenous-owned and operated casinos across Canada and the United States.
This month-long spotlight aligned with National Indigenous History Month in Canada and complemented broader efforts to recognize the sovereignty of First Nations, Inuit, Métis, and Native American communities.
'We're proud to help shine a spotlight on these tribal and First Nation casinos,' said Lee Gwilliam, SVP at Casinos.com. 'These are organizations that go above and beyond to deliver meaningful change to their communities. The results reflect the thoughts of the community in terms of not only entertainment excellence, but dedication to cultural preservation, economic resilience, and community uplift.'
United States Winners (percentage of votes in each area):
Michigan – Soaring Eagle Casino (53%)
Operated by the Saginaw Chippewa Indian Tribe, Soaring Eagle Casino was recognized for its commitment to education, health initiatives, and economic development in the central Michigan region. From scholarships to infrastructure investment, voters praised the casino's broad and lasting contributions.
The Nimkee Memorial Wellness Center is directly funded and supported by casino-generated revenue. The Soaring Eagle Casino & Resort routinely awards the Au Gres–Sims School District and Isabella County educational entities with grants that go beyond the 2% revenue-sharing program and fund initiatives such as Chromebook access, STEM curriculum and digital learning.
Florida – Seminole Hard Rock Hotel & Casino Tampa (54%)
With deep roots in community outreach and cultural celebration, the Seminole Hard Rock Tampa was honored for its high-profile support of local nonprofit organizations, disaster relief funding, and job creation across the Tampa Bay area.
Recently, the Seminole Hard Rock made a hefty donation to disaster relief efforts targeting communities affected by Hurricanes Helene and Milton. It supports World Central Kitchen and the American Red Cross. Casino's COVID-19 efforts included donating food to Metropolitan Ministries.
California – Yaamava' Resort & Casino (44%)
The Yaamava' Resort & Casino, owned by the San Manuel Band of Mission Indians, was commended for its philanthropic leadership and expansive health, housing, and education programs that benefit the Inland Empire and beyond.
Casino famously supported wildfire relief with a $100,000 donation to the American Red Cross. Its $200,000 grant to the Inland Empire Ronald McDonald House provided housing for families of critically ill children being treated at Loma Linda University Medical Center.
Oklahoma – WinStar World Casino and Resort (49%)
A beacon of economic empowerment in southern Oklahoma, WinStar, operated by the Chickasaw Nation, earned distinction for driving regional growth, supporting healthcare access, and preserving Indigenous heritage.
The Chickasaw Nation has prioritized healthcare by establishing the Chickasaw Nation Medical Center and is invested in renewable energy projects.
Canadian Winners:
Ontario – Casino Rama Resort (55%)
Owned by the Chippewas of Rama First Nation, Casino Rama stood out for its long-standing support of local arts, youth services, and Indigenous language revitalization efforts.
Casino Rama is big on local arts initiatives, so they enjoy supporting language revitalization projects like Ojibwe classes overseen by the Culture and Research Department and local Indigenous education charities such as Inspire.
Alberta – River Cree Resort and Casino (51%)
This Enoch Cree Nation enterprise was recognized for its focus on employment opportunities, cultural awareness initiatives, and sustained investment in wellness and community development across Alberta.
Through partnerships like the Enoch-Aecon Joint Venture, the Nation works on expanding trades training for Indigenous workers. The Nation also collaborates with educational advocates like Ever Active Schools, which described their work together as 'a partnership, a friendship, and a commitment to the wellbeing of the community.'
Saskatchewan – Dakota Dunes Casino (56%)
Operated by the Saskatchewan Indian Gaming Authority (SIGA), Dakota Dunes Casino led voter sentiment for its impactful community programs, including education funding and mental health services in partnership with First Nations organizations.
Dakota Dunes opened a new mental health clinic with on-site access to counseling and wellness support. Major grants were awarded, such as $100,000 for Team Saskatchewan at the North American Indigenous Games, $100,000 to FSIN for a powwow, and $50,000 to Wanuskewin Heritage Park, each supporting Indigenous cultural development.
In 2023, SIGA committed $1.89 million across its casino markets to support food security, mental health services, and Indigenous youth programs, as detailed in the SIGA Annual Report 2023.
About Casinos.com and Gambling.com Group
Casinos.com is a leading source for casino news, reviews, and rankings, serving players around the world. It is part of Gambling.com Group Limited (Nasdaq: GAMB), a publicly traded company that operates more than 50 websites dedicated to helping consumers navigate regulated gambling markets.
Gambling.com Group provides trusted resources for bettors and players through editorial content, rankings, product comparisons, and expert insights, with a mission to support safe and informed entertainment.
This press release may contain forward-looking statements, including projections or expectations related to Casinos.com. Actual results may differ materially due to various risks and uncertainties. For more information, visit Gambling.com/corporate.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Canadian farmers reel as China blocks top canola seed market
By Ed White WINNIPEG, Manitoba (Reuters) -Canadian farmers are reeling from China's decision to impose hefty duties on their canola seed, after the surprise move spooked grain buyers into halting purchases and stoked worries there will be little demand for crop deliveries this autumn. China hit Canadian canola seed imports with preliminary 75.8% duties on Tuesday following an anti-dumping investigation, escalating a year-long trade dispute. Grain buyers reacted by yanking their bids to buy crops in the next few months, said Dale Leftwich, the policy manager for SaskOilseeds. "It throws everything into confusion," said Leftwich, whose organization represents oilseed growers in Saskatchewan. "It's a huge hit." China is by far Canada's biggest canola seed market and will not be easy to replace, canola trade experts told Reuters. Canada exported almost C$5 billion ($3.63 billion) of canola products to China in 2024, about 80% of which was seed, and the steep duties would likely all but end those Chinese imports if they are maintained. Futures prices fell as much as 6.5% on Tuesday, hitting a four-month low at one point, and some traders said prices could fall further if the Chinese tariffs linger. China did not say on Tuesday how long the duties would last. A permanent decision on tariffs was expected for September but the preliminary duty had some wondering whether the timeline might be extended. Farmers sell their crops to local grain elevator companies who temporarily store the grain, before loading it onto trains and then ships for export to overseas markets like China. Grain elevator companies are worried they will not be able to ship out canola seed that they buy from farmers, so are unlikely to buy more until they have a clear sense of what will happen, traders said. Farmers are wondering how they are going to pay the bank and cover bills, said Saskatchewan farmer Chris Procyk, who was having an early morning coffee with his wife when he received a flood of texts and emails about the Chinese trade action. With the Canadian canola crop maturing and within days or a few weeks of harvest, selling the crop quickly is vital for farmers who need to cover bills for expensive inputs like fertilizer that they bought on credit. "This is the worst possible time," Procyk said. ($1 = 1.3778 Canadian dollars) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Bayridge Announces Proposed Share Consolidation
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2025) - Bayridge Resources Corp. (CSE: BYRG) (OTCQB: BYRRF) (FSE: O0K) (the "Company" or "Bayridge") announces that its board of directors ("Board") has approved a share consolidation on a ten (10) for one (1) basis (the "Consolidation"). The Company currently has 73,422,979 common shares (the "Shares") issued and outstanding; following completion of the Consolidation, and subject to rounding, the Company will have approximately 7,342,297 Shares issued and outstanding. The Board believes the Consolidation will provide the Company with increased flexibility to seek financing opportunities, increase interest and improve trading liquidity. The Company does not intend to undergo a name change in conjunction with the proposed Consolidation and will provide additional details regarding the Consolidation in a subsequent news release. About Bayridge Resources Corp. Bayridge Resources Corp. is a green energy company advancing its portfolio of Canadian uranium projects. The 1,337 ha Waterbury East project is located 25 km northeast of the Cigar Lake Mine in the northeastern Athabasca Basin region. Geophysical surveys have identified a 7km long conductivity corridor where mid-2000's drilling highlighted faulted and altered basement rock with local uranium enrichment. Large sections of this corridor remain untested. The 11,142 ha Constellation project is located 60 km south of the present-day Athabasca Basin edge in an area of significant exploration activity for basement hosted uranium. Historic airborne radiometric, electromagnetic, and magnetic surveys identified electromagnetic conductors associated with magnetic lows. ON BEHALF OF THE BOARD OF DIRECTORS: For more information, please contact: Satvir Dhillon, President and Chief Executive OfficerEmail: saf@ 604-484-3031 The Canadian Securities Exchange has not reviewed this press release and does not accept responsibility for the adequacy or accuracy of this news release. Cautionary Note on Forward-Looking Information This release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation based on current expectations, estimates, forecasts, projections, beliefs and assumptions made by management of the Company. Forward-looking information is generally identified by words such as "believe", "project", "aim", "expect", "anticipate", "estimate", "intend", "strategy", "future", "opportunity", "plan", "may", "should", "will", "would", and similar expressions and, in this news release, includes statements relating to the terms and completion of the consolidation, the financial and business prospects of the Company, its assets and other matters. Although the Company believes that the expectations and assumptions on which such forward-looking information are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that it will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking information in this news release. The forward-looking information included in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release is made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, unless so required by applicable laws. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 hours ago
- Business Wire
Organigram Reports Record Third Quarter Fiscal 2025 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share 1, is pleased to announce its record results for the third quarter ended June 30, 2025 ('Q3 Fiscal 2025' or 'Q3'). Q3 FISCAL 2025 HIGHLIGHTS Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential). Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential). International Revenue: $7.4 million (+208% year-over-year, +21% sequential). Adjusted EBITDA 2: $5.7 million (+64% year-over-year, +16% sequential). Free Cash Flow 2: $5.0 million versus ($4.8) million in the prior year period. Motif Synergies: $4.2 million to date, approximately $11 million annualized; on track to hit $15 million target within 24 months of acquisition. Total Cash: $85.9 million 3, including $35.9 million of unrestricted cash; and negligible debt. #1 Market Share in Canada: #1 in vapes, #1 in pre-rolls, #1 in milled flower, #1 in concentrates, #3 in edibles, #3 in dried flower 1. Canadian Beverage Growth: Expanded distribution in Alberta, Saskatchewan, and Manitoba. U.S. Expansion: Began generating U.S. revenue, expanded distribution into new states and gained important key account listings; launched U.S. DTC (direct-to-consumer) website expanding hemp-derived THC beverage availability to 25 states subsequent to quarter end. Record Moncton Harvest: of 24,210 kilograms, driven by capacity enhancing projects and seed-based cultivation; entire Moncton facility harvest averaged over 29% THC potency. 'In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of Motif, Collective Project, and a further optimization of our product and brand portfolio,' said Beena Goldenberg, CEO of Organigram. 'With our strong Canadian market leadership now in place, we are committed to bringing our Canadian successes, underpinned by innovation and a commitment to quality, to international markets. We have grown our export business, expanded into the US, and are set to launch new brands internationally, all building towards our ambition of becoming a truly global cannabis player.' THIRD QUARTER FISCAL 2025 FINANCIAL OVERVIEW Net revenue: Net revenue increased 72% to $70.8 million, from $41.1 million in the third quarter ended June 30, 2024 ('Q3 Fiscal 2024'), primarily driven by contributions from the Motif Labs Ltd. ('Motif') acquisition and increased international sales. Adjusted gross margin 2: Adjusted gross margin was $24.2 million, or 34% of net revenue, compared to $14.6 million, or 36%, in Q3 Fiscal 2024. Organigram's standalone adjusted gross margin excluding Motif was approximately 37% in Q3. Management expects adjusted gross margin to improve over the coming quarters as Motif acquisition-related synergies are realized. Selling, general & administrative ('SG&A') expenses: SG&A increased 70% to $24.5 million from $14.4 million in Q3 Fiscal 2024. The increase was attributable to the inclusion of Motif SG&A in Organigram's consolidated financials as well as higher trade investments to support the growth of the business. As a proportion of net revenue, SG&A remained flat at 35%, compared to 35% in Q3 Fiscal 2024. Included in SG&A was an incremental investment of $1.2 million into ERP versus the prior year and higher amortization of $1.6 million associated with Motif and Collective Project Limited ('Collective Project') acquisitions. Net loss: Net loss was $6.3 million compared to net income of $2.8 million in Q3 Fiscal 2024. The decrease in net income from the prior period is primarily attributable to higher fair value changes recognized in relation to the preferred shares and top-up-rights held by British American Tobacco p.l.c ('BAT'), and other financial instruments. Adjusted EBITDA 4: Adjusted EBITDA was $5.7 million compared to $3.5 million in adjusted EBITDA in Q3 Fiscal 2024. The increase was primarily attributable to higher recreational revenue, including Motif contributions, and higher international revenue. Net cash from operating activities: Net cash from operating activities was $14.6 million, compared to cash used of $3.7 in Q3 Fiscal 2024. The increase was primarily attributable to improved working capital utilization. 'In Q3 we delivered solid revenue and adjusted EBITDA growth sequentially and year-over-year while making significant progress toward the full integration of our recent acquisitions,' said Greg Guyatt, CFO of Organigram. 'As our business continues to scale domestically and abroad, and the realization of cost synergies related to our Motif acquisition begin to positively impact future earnings, we are confident in our trajectory toward sustained profitability and free cash flow in the near-term.' CANADIAN RECREATIONAL MARKET INTRODUCTIONS As Canada's market leader in recreational cannabis, Organigram remains committed to delivering consumer focused innovations and products to its customers. Some notable recent highlights include: SHRED Max10 Party Pack: Ten individual 10mg gummies separately packaged within a container to provide consumers with 100mg THC per container. Big Bag O' Buds: New strains in Blueberry Dream, UK Cheddar Cheese, and Comboz (Ultra Sour & Blueberry Dream). SHRED Flower Power: The return of the OG SHRED blend — A sativa blend boasting strong sweet and floral aromas. BOXHOT IPRs: Pear Herer & Strawberry Diesel infused pre-rolls. Trailblazer Blunts: Tube-style blunts wrapped in tea leaf-based blunt paper for a smooth and unique flavour profile. Rizzlers Vapes: Lime Frizz & Passion Plunge all-in-one switch-hit vapes. INTERNATIONAL SALES In Q3 Fiscal 2025, Organigram achieved $7.4 million in international sales compared to $2.4 million in the same prior year period, and expects to continue growing its international sales over time. Organigram continues to await EU-GMP certification for its Moncton facility. In Q3 Fiscal 2025, Organigram began generating U.S. recreational revenue from hemp-derived THC beverage pursuant to the acquisition of Collective Project. BALANCE SHEET & LIQUIDITY As of June 30, 2025, the Company had total cash (including restricted cash and short-term investments) of $85.9 million. Select Key Financial Metrics (in $000s unless otherwise indicated) Q3-2025 Q3-2024 % Change Gross revenue 110,205 63,605 73 % Excise taxes (39,413 ) (22,545 ) 75 % Net revenue 70,792 41,060 72 % Cost of sales 48,369 27,173 78 % Gross margin before fair value changes to biological assets & inventories sold 22,423 13,887 61 % Realized fair value on inventories sold and other inventory charges (14,461 ) (13,728 ) 5 % Unrealized gain on changes in fair value of biological assets 18,184 13,849 31 % Gross margin 26,146 14,008 87 % Adjusted gross margin (1) 24,226 14,586 66 % Adjusted gross margin % (1) 34 % 36 % (2 )% Selling (including marketing), general & administrative expenses 24,504 14,376 70 % Net (loss) income (6,294 ) 2,818 nm Adjusted EBITDA (1) 5,694 3,465 64 % Net cash used in operating activities before working capital changes (686 ) (182 ) 277 % Net cash provided by (used in) operating activities after working capital changes 14,626 (3,730 ) nm Note (1) Adjusted gross margin, adjusted gross margin % and adjusted EBITDA are non-IFRS financial measures not defined by and do not have any standardized meaning under IFRS and might not be comparable to similar financial measures disclosed by other issuers; please refer to 'Non-IFRS Financial Measures' in this press release for more information. Expand Select Balance Sheet Metrics (in $000s) JUNE 30, 2025 SEPTEMBER 30, 2024 % Change Cash & short-term investments (including restricted cash) 85,931 133,426 (36 )% Biological assets & inventories 125,186 82,524 52 % Other current assets 66,666 46,269 44 % Accounts payable & accrued liabilities 89,803 47,097 91 % Current portion of long-term debt 40 60 (33 )% Working capital 170,508 208,897 (18 )% Property, plant & equipment 123,537 96,231 28 % Long-term debt — 25 (100 )% Total assets 564,615 407,860 38 % Total liabilities 179,119 101,871 76 % Shareholders' equity 385,496 305,989 26 % Expand The following table reconciles the Company's adjusted EBITDA to net loss. Adjusted EBITDA Reconciliation (in $000s unless otherwise indicated) Q3-2025 Q3-2024 Net (loss) income as reported $ (6,294 ) $ 2,818 Add/(deduct): Investment income, net of financing costs (73 ) (1,179 ) Income tax (recovery) expense (9,903 ) — Depreciation and amortization 4,789 3,039 ERP implementation costs 1,217 7 Acquisition and other transaction costs 654 421 Inventory and biological assets fair value and NRV adjustments (2,787 ) 578 Acquisition-related fair value adjustment to inventory sold 897 — Share-based compensation 1,007 2,087 Other (income) expenses(1) 13,511 (6,687 ) Research and development expenditures, net of depreciation 2,676 2,381 Adjusted EBITDA $ 5,694 $ 3,465 Note 1: Other (income) expenses includes share of loss from investments in associates, (gain) loss on disposal of property, plant and equipment, change in fair value of derivative liabilities, preferred shares, contingent consideration and other financial assets, and certain other non-operating (income) expenses. Expand The following table reconciles the Company's adjusted gross margin to gross margin before fair value changes to biological assets and inventories sold: The following table reconciles the Company's Free Cash Flow to net cash and restricted cash provided by (used in) operating activities: Third Quarter Fiscal 2025 Conference Call The Company will host a conference call to discuss its results with details as follows: Date: August 13, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use this link: To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. To access the webcast: A replay of the webcast will be available within 24 hours after the conclusion of the call at and will be archived for a period of 90 days following the call. Non-IFRS Financial Measures This news release refers to certain financial performance measures (including adjusted gross margin, adjusted gross margin %, adjusted EBITDA and Free Cash Flow) that are not defined by and do not have a standardized meaning under IFRS as issued by the International Accounting Standards Board. Non-IFRS financial measures are used by management to assess the financial and operational performance of the Company. The Company believes that these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company's operating results, underlying performance and prospects in a similar manner to the Company's management. As there are no standardized methods of calculating these non-IFRS measures, the Company's approaches may differ from those used by others, and accordingly, the use of these measures may not be directly comparable. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Adjusted EBITDA is a non-IFRS measure that the Company defines as net income (loss) before: net of financing costs; income tax expense (recovery); depreciation, amortization, impairment, normalization of depreciation add-back due to changes in depreciable assets resulting from impairment charges, (gain) loss on disposal of property, plant and equipment (per the consolidated statement of cash flows); share-based compensation (per the consolidated statement of cash flows); share of loss (gain) from investments in associates including impairment loss; change in fair value of contingent consideration; change in fair value of derivative liabilities, other financial assets and preferred shares; expenditures incurred in connection with research and development ("R&D") activities (net of depreciation); unrealized gain on changes in fair value of biological assets; realized fair value on inventories sold and other inventory charges; provisions and net realizable value adjustments related to inventory and biological assets; government subsidies, insurance recoveries and other non-operating expenses (income); legal provisions (recoveries); incremental fair value component of inventories sold from acquisitions; ERP implementation costs; transaction costs; share issuance costs; and provision for expected credit losses . Adjusted EBITDA is intended to provide a proxy for the Company's operating cash flow and derive expectations of future financial performance for the Company, and excludes adjustments that are not reflective of current operating results. Adjusted gross margin is a non-IFRS measure that the Company defines as net revenue less cost of sales, before the effects of (i) unrealized gain on changes in fair value of biological assets; (ii) realized fair value on inventories sold and other inventory charges; (iii) provisions and impairment of inventories and biological assets; and (iv) provisions to net realizable value. Adjusted gross margin % is calculated by dividing adjusted gross margin by net revenue. Management believes that these measures provide useful information to assess the profitability of our operations as they represent the normalized gross margin generated from operations and exclude the effects of non-cash fair value adjustments on inventories and biological assets, which are required by IFRS. Free Cash Flow is a non-IFRS measure that the Company defines as net cash provided by or used in operating activities less the purchase of property, plant and equipment. Management believes this measure is a useful indicator of the Company's capacity to fund operations from internally generated cash flows, without the need for additional borrowings or use of existing cash reserves under normal operating conditions. The most directly comparable measure to adjusted EBITDA, calculated in accordance with IFRS is net income (loss) and beginning on page 5 of this press release is a reconciliation to such measure. The most directly comparable measure to adjusted gross margin calculated in accordance with IFRS is gross margin before fair value changes to biological assets and inventories sold and beginning on page 5 of this press release is a reconciliation to such measure. The most directly comparable measure to Free Cash Flow is net cash and restricted cash provided by (used in) operating activities, and beginning on page 5 of this press release is a reconciliation to such measure. About Organigram Global Inc. Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly-owned subsidiaries include Organigram Inc., a licensed cultivator or cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project, Organigram Global participates in the U.S. and Canadian cannabinoid beverages markets. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Québec, with a dedicated manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Forward-Looking Information This news release contains forward-looking information. Forward-looking information, in general, can be identified by the use of forward-looking terminology such as 'outlook', 'objective', 'may', 'will', 'could', 'would', 'might', 'expect', 'intend', 'estimate', 'anticipate', 'believe', 'plan', 'continue', 'budget', 'schedule' or 'forecast' or similar expressions suggesting future outcomes or events. They include, but are not limited to, statements with respect to expectations, projections or other characterizations of future events or circumstances, and the Company's objectives, goals, strategies, beliefs, intentions, plans, estimates, forecasts, projections and outlook, including statements relating to the Company's future performance, the Company's positioning to capture additional market share and sales including international sales, expectations for consumer demand, expected improvement to gross margins before fair value changes to biological assets and inventories, expectations regarding adjusted gross margins, adjusted EBITDA, Free Cash Flow and net revenue in Fiscal 2025 and beyond, expectations regarding cultivation capacity, the Company's plans and objectives including around the PDC, availability and sources of any future financing, availability of cost efficiency opportunities, the ability of the Company to fulfill demand for its revitalized product portfolio with increased staffing, expectations relating to greater capacity to meet demand due to increased capacity at the Company's facilities, expectations around lower product cultivation costs, the ability to achieve economies of scale and ramp up cultivation, expectations pertaining to the increase of automation and reduction in reliance on manual labour, expectations around the launch of higher margin dried flower strains, expectations around market and consumer demand and other patterns related to existing, new and planned product forms; expectations regarding the Company's acquisition, integration and synergy realization of Motif and Collective Project; expectations around FASTTM nanoemulsion technology; expectations regarding EU-GMP certification; timing for launch of new product forms, ability of those new product forms to capture sales and market share, estimates around incremental sales and more generally estimates or predictions of actions of customers, suppliers, partners, distributors, competitors or regulatory authorities; statements regarding the future of the Canadian and international cannabis markets and, statements regarding the Company's future economic performance. These statements are not historical facts but instead represent management beliefs regarding future events, many of which, by their nature are inherently uncertain and beyond management control. Forward-looking information has been based on the Company's current expectations about future events. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. These risks, uncertainties and factors include: general economic factors; international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures; changes to government laws, regulations or policies, including customs, tariffs, trade or environmental law, regulations or policies, or the enforcement thereof; receipt of regulatory approvals or consents and any conditions imposed upon same and the timing thereof; the Company's ability to meet regulatory criteria which may be subject to change; change in regulation including restrictions on sale of new product forms; change in stock exchange listing practices; the Company's ability to manage costs, timing and conditions to receiving any required testing results and certifications; results of final testing of new products; changes in governmental plans including those related to methods of distribution; timing and nature of sales and product returns; customer buying patterns and consumer preferences not being as predicted given this is a new and emerging market; material weaknesses identified in the Company's internal controls over financial reporting; the completion of regulatory processes and registrations including for new products and forms; market demand and acceptance of new products and forms; unforeseen construction or delivery delays including of equipment and commissioning; increases to expected costs; competitive and industry conditions; change in customer buying patterns; and changes in crop yields. These and other risk factors are disclosed in the Company's documents filed from time to time under the Company's issuer profile on the Canadian Securities Administrators' System for Electronic Document Analysis and Retrieval+ ('SEDAR') at and reports and other information filed with or furnished to the United States Securities and Exchange Commission ('SEC') from time to time on the SEC's Electronic Document Gathering and Retrieval System ('EDGAR') at including the Company's most recent management discussion and analysis ('MD&A') and annual information form. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward looking information is subject to risks and uncertainties that are addressed in the 'Risk Factors' section of the MD&A dated August 12, 2025 and there can be no assurance whatsoever that these events will occur. This news release contains information concerning our industry and the markets in which we operate, including our market position and market share, which is based on information from independent third-party sources. Although we believe these sources to be generally reliable, market and industry data is inherently imprecise, subject to interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature of the data gathering process, and other limitations and uncertainties inherent in any statistical survey or data collection process. We have not independently verified any third-party information contained herein.
